Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-028827

Vice President, Finance sold 4,884 shares at $11.72 ($57,219)

From the SEC's structured data for this filing

Trades in this filing

Tourangeau Greg · Vice President, Finance

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-08 Sale : show line 1 in the form −4,884 $11.72 $57,219 11,807 D
Open-market sales · 4,884 sh · avg $11.72 · $57,219
Loading xslF345X05/ownership.xml…